4//SEC Filing
Kite Pharma, Inc. 4
Accession 0001209191-16-125833
CIK 0001510580operating
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 7:10 PM ET
Size
8.2 KB
Accession
0001209191-16-125833
Insider Transaction Report
Form 4
Ruchefsky Steven B
Director
Transactions
- Award
Common Stock
2016-06-01+1,950→ 87,988 total - Award
Director Stock Option (Right to Buy)
2016-06-01+7,000→ 7,000 totalExercise: $50.87Exp: 2026-05-31→ Common Stock (7,000 underlying)
Holdings
- 946,420(indirect: See Footnote)
Common Stock
Footnotes (3)
- [F1]Includes 86,038 shares, previously registered in the name of Commercial Street Capital, LLC, which were distributed to the Reporting Person on March 27, 2015 in a pro rata distribution and are now owned directly.
- [F2]The shares are held in the name of Commercial Street Capital, LLC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
- [F3]The stock option shall vest in 24 successive equal monthly installments following the date of grant.
Documents
Issuer
Kite Pharma, Inc.
CIK 0001510580
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001510580
Filing Metadata
- Form type
- 4
- Filed
- Jun 2, 8:00 PM ET
- Accepted
- Jun 3, 7:10 PM ET
- Size
- 8.2 KB